Maternal medicine in the COVID era

Sophie Relph, Shakila Thangaratinam

Research output: Contribution to journalReview articlepeer-review


The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.

Original languageEnglish
Pages (from-to)113-124
JournalBest Practice & Research: Clinical Obstetrics & Gynaecology
Early online date18 Mar 2021
Publication statusPublished - Jun 2021


  • COVID-19
  • Co-morbidities
  • Maternal medicine
  • Pregnancy
  • Prenatal care
  • SARS-CoV-2
  • Pandemics
  • Humans
  • Pregnancy Complications, Infectious/epidemiology
  • Pregnant Women
  • Female

ASJC Scopus subject areas

  • Obstetrics and Gynaecology


Dive into the research topics of 'Maternal medicine in the COVID era'. Together they form a unique fingerprint.

Cite this